MIMEDX GROUP, INC.
Last · —$4.70+0.01 (+0.21%)live · yahoo · 1h ago
Market cap$685.89M—
P/E · TTM118fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $355.2M |
|---|---|
| Operating income | $-34.5M |
| Net income | $-25.7M |
| Operating margin | -9.7% |
| Net margin | -7.2% |
| Return on equity | -11.9% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2023-02-28
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -13.7%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -6.7%
- Accumulated Deficit High — Accumulated deficit / equity 258%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.00
Est. revenue
68.7M
Earnings transcripts
Press & signals
- GlobeNewswire
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
- GlobeNewswire
MIMEDX to Acquire Sanara MedTech
Documents
FormReporting forFiledFlags